ATE354589T1 - Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese - Google Patents

Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Info

Publication number
ATE354589T1
ATE354589T1 AT01974427T AT01974427T ATE354589T1 AT E354589 T1 ATE354589 T1 AT E354589T1 AT 01974427 T AT01974427 T AT 01974427T AT 01974427 T AT01974427 T AT 01974427T AT E354589 T1 ATE354589 T1 AT E354589T1
Authority
AT
Austria
Prior art keywords
cyclopeptides
preparation
inhibiting
angiogenesis
stimulating angiogenesis
Prior art date
Application number
AT01974427T
Other languages
English (en)
Inventor
Natacha Betz
Andreas Bikfalvi
Gerard Deleris
Original Assignee
Commissariat Energie Atomique
Univ Victor Segalen Bordeaux 2
Univ Bordeaux 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Victor Segalen Bordeaux 2, Univ Bordeaux 1 filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE354589T1 publication Critical patent/ATE354589T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01974427T 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese ATE354589T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (1)

Publication Number Publication Date
ATE354589T1 true ATE354589T1 (de) 2007-03-15

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01974427T ATE354589T1 (de) 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Country Status (15)

Country Link
US (2) US7199100B2 (de)
EP (1) EP1328546B1 (de)
JP (1) JP4303958B2 (de)
AT (1) ATE354589T1 (de)
AU (2) AU9394801A (de)
CA (1) CA2424506A1 (de)
DE (1) DE60126802T2 (de)
DK (1) DK1328546T3 (de)
ES (1) ES2282293T3 (de)
FR (1) FR2814744B1 (de)
IL (1) IL155117A0 (de)
NO (1) NO20031377L (de)
NZ (1) NZ525069A (de)
RU (1) RU2249599C2 (de)
WO (1) WO2002028895A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (de) 2002-03-01 2007-03-21 Dyax Corp Kdr und vegf/kdr-bindende peptide und ihre diagnostische und therapeutische veranwendung bei der diagnose und therapie
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
EP2284180B1 (de) 2003-03-03 2015-09-09 Dyax Corp. Verwendungen von Spezifisch an HGF-Rezeptor (cMET) bindenden Peptiden
DE602007005349D1 (de) * 2006-01-17 2010-04-29 Organon Nv SELEKTIVE ENZYMATISCHE HYDROLYSE VON C-TERMINALEN tert-BUTYL-PEPTIDESTERN
JP5186632B2 (ja) 2006-10-19 2013-04-17 ブリッタ ハーディ, 血管形成を誘導するための組成物および方法
US8741850B2 (en) * 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
US9815867B2 (en) 2012-09-03 2017-11-14 The University Of Tokyo Peptide for inhibiting vascular endothelial growth factor receptor
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237456A1 (de) * 1992-11-06 1994-05-11 Merck Patent Gmbh Cyclopeptide
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
EP0844252A3 (de) * 1996-11-15 1998-07-08 Remacle, José Zyklische Peptide mit einer zur anschliessenden chemischen Kupplung entworfenen Zweiggruppe und Verfahren zu deren Herstellung
EP1056773A2 (de) * 1998-02-11 2000-12-06 Resolution Pharmaceuticals Inc. Für angiogenese spezifische moleküle
WO2000053219A2 (en) * 1999-03-11 2000-09-14 Entremed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders

Also Published As

Publication number Publication date
RU2249599C2 (ru) 2005-04-10
FR2814744A1 (fr) 2002-04-05
NZ525069A (en) 2004-09-24
US20040092434A1 (en) 2004-05-13
JP4303958B2 (ja) 2009-07-29
DE60126802T2 (de) 2007-11-08
USRE44022E1 (en) 2013-02-19
IL155117A0 (en) 2003-10-31
NO20031377D0 (no) 2003-03-26
EP1328546A2 (de) 2003-07-23
JP2004510784A (ja) 2004-04-08
AU9394801A (en) 2002-04-15
CA2424506A1 (en) 2002-04-11
ES2282293T3 (es) 2007-10-16
EP1328546B1 (de) 2007-02-21
DK1328546T3 (da) 2007-06-04
NO20031377L (no) 2003-05-02
FR2814744B1 (fr) 2002-11-29
AU2001293948B2 (en) 2005-11-03
WO2002028895A2 (fr) 2002-04-11
WO2002028895A3 (fr) 2002-06-06
US7199100B2 (en) 2007-04-03
DE60126802D1 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
DE60126802D1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
DE69925156D1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
GB9927292D0 (en) Security system
NO942110L (no) Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav
AU5155996A (en) Control of pod dehiscence
WO2003040370A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
PT989858E (pt) Compostos que imitam os peptideos inibidores de cd28/ctla-composicoes farmaceuticas feitas a partir dos referidos e um metodo de usar os referidos
DE602004025265D1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
DK0894091T3 (da) Fremgangsmåde til oprensning af et protein fra en proteinholdig opløsning
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
EP0624100A4 (en) Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof.
DE69923460D1 (de) Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
PT773999E (pt) Receptor orfao or-1 pertencente a familia de receptores nucleares
IT1277391B1 (it) Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
ATE401408T1 (de) Tapetum-spezifische promotoren
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
AU1993201A (en) Nucleic acid sequences of hyperplasia and tumours of the thyroid
ES2109373T3 (es) Nueva proteina inhibidora de trombina a partir de garrapatas.
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1328546

Country of ref document: EP

REN Ceased due to non-payment of the annual fee